Trial Profile
A Preliminary Evaluation of the Safety and Pancreas Imaging Properties of 18F-AV-133 in Healthy Volunteers and in Patients With Type 1 or Type 2 Diabetes
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Florbenazine F18 (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 09 Jan 2020 Status changed from suspended to discontinued.
- 13 May 2014 New trial record